{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:39:12Z","timestamp":1780389552071,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI137332\\u201302"],"award-info":[{"award-number":["R01 AI137332\\u201302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24 AI120942"],"award-info":[{"award-number":["R24 AI120942"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.virol.2020.11.010","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T04:29:11Z","timestamp":1612585751000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Designing multivalent immunogens for alphavirus vaccine optimization"],"prefix":"10.1016","volume":"561","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-4161","authenticated-orcid":false,"given":"C.M.","family":"Read","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Rafael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannan L.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-2109","authenticated-orcid":false,"given":"Catherine H.","family":"Schein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2020.11.010_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","author":"Anderson","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2020.11.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.78.1.1-8.2004","article-title":"Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus","volume":"78","author":"Anishchenko","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib3","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.vaccine.2009.05.011","article-title":"Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus","volume":"27","author":"Atasheva","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib4","doi-asserted-by":"crossref","first-page":"104905","DOI":"10.1016\/j.antiviral.2020.104905","article-title":"Producing physicochemical property consensus alphavirus protein antigens for broad spectrum vaccine design","volume":"182","author":"Baker","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2020.11.010_bib5","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.vaccine.2012.07.042","article-title":"Simplifying complex sequence information: a PCP-consensus protein binds antibodies against all four Dengue serotypes","volume":"30","author":"Bowen","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib6","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1128\/JVI.76.12.6387-6392.2002","article-title":"Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein","volume":"76","author":"Brault","year":"2002","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.virol.2020.11.010_bib1a","article-title":"D-graph clusters flaviviruses and \u03b2-coronaviruses according to their hosts, disease type and human cell receptors","volume":"08","author":"Braun","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.virol.2020.11.010_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2019.01.015","article-title":"New World alphavirus protein interactomes from a therapeutic perspective","volume":"163","author":"Carey","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2020.11.010_bib8","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJMoa1212628","article-title":"Eastern equine encephalitis in Latin America","volume":"369","author":"Carrera","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2020.11.010_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1128\/JVI.01860-12","article-title":"A chimeric vesiculo\/alphavirus is an effective alphavirus vaccine","volume":"87","author":"Chattopadhyay","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib10","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1128\/JVI.02886-12","article-title":"A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein","volume":"87","author":"Chen","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s40259-013-0046-1","article-title":"Emerging targets and novel approaches to Ebola virus prophylaxis and treatment","volume":"27","author":"Choi","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.virol.2020.11.010_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2020.11.010_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1504\/IJBRA.2010.032117","article-title":"Flavitrack analysis of the structure and function of West Nile non-structural proteins","volume":"6","author":"Danecek","year":"2010","journal-title":"Int. J. Bioinf. Res. Appl."},{"key":"10.1016\/j.virol.2020.11.010_bib14","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jmb.2009.11.070","article-title":"PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype","volume":"396","author":"Danecek","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2020.11.010_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.coviro.2012.02.014","article-title":"Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives","volume":"2","author":"Dupuy","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.virol.2020.11.010_bib16","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1016\/j.vaccine.2009.04.049","article-title":"Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine","volume":"27","author":"Dupuy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01274-17","article-title":"Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge","volume":"92","author":"Erasmus","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005693","article-title":"Evolution and spread of Venezuelan equine encephalitis complex alphavirus in the Americas","volume":"11","author":"Forrester","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2020.11.010_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.onehlt.2017.06.001","article-title":"Emerging arboviruses: why today?","volume":"4","author":"Gould","year":"2017","journal-title":"One Health"},{"key":"10.1016\/j.virol.2020.11.010_bib20","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine"},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2020.11.010_bib21","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1086\/431500","article-title":"Development of a pentavalent rotavirus vaccine against prevalent serotypes of rotavirus gastroenteritis","volume":"192","author":"Heaton","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2020.11.010_bib22","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.1128\/JVI.03361-12","article-title":"Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus","volume":"87","author":"Herbert","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01119-14","article-title":"Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses","volume":"5","author":"Holmblat","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.virol.2020.11.010_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037398","article-title":"Multiple interferon stimulated genes synergize with the zinc finger antiviral protein to mediate anti-alphavirus activity","volume":"7","author":"Karki","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.virol.2020.11.010_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/14760584.2017.1299576","article-title":"Strategies to induce broadly protective antibody responses to viral glycoproteins","volume":"16","author":"Krammer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2020.11.010_bib26","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1038\/ncomms12838","article-title":"A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques","volume":"7","author":"Lee","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2020.11.010_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1089\/dna.2005.24.256","article-title":"DNA shuffling and screening strategies for improving vaccine efficacy","volume":"24","author":"Locher","year":"2005","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.virol.2020.11.010_bib28","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/prot.24027","article-title":"Engineering proteins with enhanced mechanical stability by force-specific sequence motifs","volume":"80","author":"Lu","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.virol.2020.11.010_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molimm.2018.03.022","article-title":"Distinguishing allergens from non-allergenic homologues using Physical-Chemical Property (PCP) motifs","volume":"99","author":"Lu","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.virol.2020.11.010_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011815","article-title":"HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach","volume":"5","author":"Matthews","year":"2010","journal-title":"PloS One"},{"key":"10.1016\/j.virol.2020.11.010_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-3292-4_1","article-title":"An introduction to poliovirus: pathogenesis, vaccination, and the endgame for global eradication","volume":"1387","author":"Minor","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2020.11.010_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.virol.2011.08.007","article-title":"A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+\/CCR5+ cells","volume":"419","author":"Mourez","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2020.11.010_bib3a","doi-asserted-by":"crossref","first-page":"14622","DOI":"10.1073\/pnas.1204787109","article-title":"Eilat virus, a unique alphavirus with host range restricted to insects by RNA replication","volume":"109","author":"Nasar","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.virol.2020.11.010_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00894-006-0101-7","article-title":"Determining functionally important amino acid residues of the E1 protein of Venezuelan equine encephalitis virus","volume":"12","author":"Negi","year":"2006","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.virol.2020.11.010_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12985-014-0215-y","article-title":"pH-Dependent entry of chikungunya virus fusion into mosquito cells","volume":"11","author":"Nuckols","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.virol.2020.11.010_bib35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib36","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1016\/j.vaccine.2009.02.090","article-title":"Immune interference after sequential alphavirus vaccine vaccinations","volume":"27","author":"Pittman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib37","doi-asserted-by":"crossref","first-page":"9616","DOI":"10.1128\/JVI.01286-14","article-title":"Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies","volume":"88","author":"Porta","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2020.11.010_bib38","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1016\/j.vaccine.2012.09.049","article-title":"Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: eastern equine and western equine encephalitis","volume":"30","author":"Reisler","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib39","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2019.1574149","article-title":"51 years in of Chikungunya clinical vaccine development: a historical perspective","volume":"15","author":"Reyes-Sandoval","year":"2019","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2020.11.010_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.virol.2012.11.013","article-title":"IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice","volume":"437","author":"Rossi","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2020.11.010_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003797","article-title":"IRES-containing VEEV vaccine protects cynomolgus macaques from IE Venezuelan equine encephalitis virus aerosol challenge","volume":"9","author":"Rossi","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virol.2020.11.010_bib42","volume":"vol. 8","author":"Rossi","year":"2020"},{"issue":"Suppl. 13","key":"10.1016\/j.virol.2020.11.010_bib43","article-title":"Physicochemical property consensus sequences for functional analysis, design of multivalent antigens and targeted antivirals","volume":"13","author":"Schein","year":"2012","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.virol.2020.11.010_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virol.2015.05.016","article-title":"Sequence specificity for uridylylation of the viral peptide linked to the genome (VPg) of enteroviruses","volume":"484","author":"Schein","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2020.11.010_bib45","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.bmc.2015.12.023","article-title":"Allosteric inhibitors of Coxsackie virus A24 RNA polymerase","volume":"24","author":"Schein","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virol.2020.11.010_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.4269\/ajtmh.1964.13.723","article-title":"The Venezuelan equine encephalomyelitis complex of group a arthropod-borne viruses, including Mucambo and pixuna from the amazon region of Brazil","volume":"13","author":"Shope","year":"1964","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2020.11.010_bib47","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1021\/jm300214e","article-title":"Novel inhibitors of neurotropic alphavirus replication that improve host survival in a mouse model of acute viral encephalitis","volume":"55","author":"Sindac","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virol.2020.11.010_bib48","volume":"vol. 8","author":"Stromberg","year":"2020"},{"key":"10.1016\/j.virol.2020.11.010_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fmicb.2017.00081","article-title":"Live, attenuated Venezuelan equine encephalitis virus vaccine (TC83) causes persistent brain infection in mice with non-functional alphabeta T-cells","volume":"8","author":"Taylor","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2020.11.010_bib50","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1016\/j.vaccine.2020.02.007","article-title":"Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge","volume":"38","author":"Tretyakova","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/14760584.2014.944168","article-title":"Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses?","volume":"13","author":"Trobaugh","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2020.11.010_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00894-001-0058-5","article-title":"New quantitative descriptors of amino acids based on multidimensional scaling of a large number of physical\u2013chemical properties","volume":"7","author":"Venkatararajan","year":"2001","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.virol.2020.11.010_bib53","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1016\/j.vaccine.2008.07.054","article-title":"Chimeric alphavirus vaccine candidates for chikungunya","volume":"26","author":"Wang","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2020.11.010_bib54","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2012.04.002","article-title":"Alphaviruses: population genetics and determinants of emergence","volume":"94","author":"Weaver","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2020.11.010_bib55","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4269\/ajtmh.14-0055","article-title":"Current strategic thinking for the development of a trivalent alphavirus vaccine for human use","volume":"91","author":"Wolfe","year":"2014","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2020.11.010_bib56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.virol.2010.03.038","article-title":"Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III","volume":"403","author":"Zhang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2020.11.010_bib57","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/protein\/gzt010","article-title":"Thermodynamic stability of domain III from the envelope protein of flaviviruses and its improvement by molecular design","volume":"26","author":"Zidane","year":"2013","journal-title":"Protein Eng. Des. Sel."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682220302361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682220302361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:03:40Z","timestamp":1778627020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682220302361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":59,"alternative-id":["S0042682220302361"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2020.11.010","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Designing multivalent immunogens for alphavirus vaccine optimization","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2020.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}